Classification:
1.Natural
|
Cortisol(t½:1-1.5hr)
Hydrocortisone
|
|
2.Synthetic
|
[A]Short acting
(8-12 hours)
|
Prednisolone
Prednisone
Methyl-prednisolone
|
[B]Intermediate acting
(12-36 hours)
|
Flu-prednisolone
Paramethasone
Triamcinolone
|
|
[C]Long acting
(36-72 hours)
|
Dexamethasone
Betamethasone
Beclomethasone
|
Mechanism of action/
Prednisolone/Dexamethasone/Glucocorticoids::
Glucocorticoids
↓
Enter into the cell
↓
Bind with specific protein in the
cytoplasm
↓
Steroid receptor complex
↓
The complex enters into the nucleus
↓
Binds with (GRE)glucocorticoid
receptor element of specific gene
↓
Transcription reaction
↓
mRNA in the cytoplasm
↓
Synthesis of new protein
↓
New protein is responsible for
various effects of steriod.
Adverse effect /Prednisolone/Dexamethasone/ Glucocorticoids:
1)
Cushing’s syndrome.
2)
Avascular necrosis of bone.
3)
Insomnia.
4)
Diabetic mellitus.
5)
Glucoma.
6)
Increased intra-cranial pressure.
7)
Fever.
8)
Nausea,dizzines,weight.
Indications/Prednisolone/Dexamethasone/Glucocorticoids:
1)
Allergic reaction:
·
Asthma.
·
Allergic rhinitis.
·
Urticaria.
·
Anphylactic shock.
2)
Bone and joint disease:
·
Arthritis.
·
Bursitis.
·
Sinuvitis.
3)
Collagen vascular disease:
·
SLE.
·
Rheumatoid arthritis.
4)
Dermatological diseases:
·
Atopic dermatitis.
·
Contact dermatitis.
·
Seborrheic dermatitis.
5)
Eye disease:
·
Acute uveitis.
·
Choroiditis.
·
Optic neuritis.
6)
Joint disease.
7)
Kidney disease:nephrotic syndrome.
8)
Lung disease:
·
Bronchial asthma.
·
Infant respiratory distress.
·
Aspiraton pneumonia.
9)
Neurological disorders:
·
Cerebral oedema.
·
Multiple sclerosis.
10)
Sub-acute thyroiditis.
Contraindication:
1)
Cushing syndrome(absolute contraindication)
2)
Peptic ulcer.
3)
DM.
4)
Infection.
5)
Osteoporosis.
6)
HTN.
7)
CCF.
8)
Children(because glucocorticoids cause growth reterdation).
9)
Psychosis.
10)
Glaucoma.
11)
Epilepsy.
12)
TB.
13)
Renal dysfunction.
14)
Thrombo-embolism.
Difference between Prednisolone & Ketoprofen:
Trait
|
Prednisolone
|
Ketoprofen
|
1.Type
|
Steroidal anti-inflammatory
|
Non-steroidal anti-inflammatory
|
2.M/A
|
Inhibit phospholipase A2→No arachidonic
acid synthesis from member phospholipids→ so no PG,LT→ anti- inflammatory action
|
Inhibit cycloxygenase→No PG
synthesis from arachidonic acid→So no mediators of
inflammation→Anti-inflammatory action
|
3.Adverse effects
|
Cushing syndrome,
Insomnia,DM,Avascular necrosis of
bone.
|
PUD,Headache,Dizziness,
Neutropenia.
|
মন্তব্যসমূহ
একটি মন্তব্য পোস্ট করুন